Faculty Opinions recommendation of Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969276.793468807 ◽

2013 ◽

Author(s):

Thomas Stinchcombe

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

Phase 2 Study

Download Full-text

Faculty Opinions recommendation of Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969276.793473915 ◽

2013 ◽

Cited By ~ 1

Author(s):

Sam Janes ◽

Laura Succony

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

Phase 2 Study

Download Full-text

P82.02 Stereotactic Ablative Radiotherapy with Nivolumab for Early-Stage Operable Non-Small Cell Lung Cancer: a phase 2 study

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.01.1193 ◽

2021 ◽

Vol 16 (3) ◽

pp. S651-S652

Author(s):

J. Beal ◽

D. Gomes ◽

P. Taranto ◽

L. Koch ◽

A.C. Rezende ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Early Stage ◽

Small Cell ◽

Stereotactic Ablative Radiotherapy ◽

Phase 2 ◽

Small Cell Lung ◽

Phase 2 Study

Download Full-text

Anlotinib vs placebo as third- or further-line treatment for patients with small cell lung cancer: a randomised, double-blind, placebo-controlled Phase 2 study

British Journal of Cancer ◽

10.1038/s41416-021-01356-3 ◽

2021 ◽

Author(s):

Ying Cheng ◽

Qiming Wang ◽

Kai Li ◽

Jianhua Shi ◽

Ying Liu ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Line Treatment ◽

Phase 2 ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Phase 2 Study

Download Full-text

P2.01-19 Phase 2 Study of Telisotuzumab Vedotin (Teliso-V) in Previously Treated c-MET+ Non-Small Cell Lung Cancer: Trial in Progress

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2019.08.1363 ◽

2019 ◽

Vol 14 (10) ◽

pp. S646 ◽

Cited By ~ 1

Author(s):

C. Ocampo ◽

J. Wu ◽

J. Dey ◽

Z. Sun ◽

M. Motwani ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

Cancer Trial ◽

Phase 2 Study ◽

Previously Treated

Download Full-text

Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancer

Lung Cancer ◽

10.1016/j.lungcan.2011.09.006 ◽

2012 ◽

Vol 76 (1) ◽

pp. 78-83 ◽

Cited By ~ 22

Author(s):

Benjamin Besse ◽

David Planchard ◽

Anne-Sophie Veillard ◽

Laurent Taillade ◽

David Khayat ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

Phase 2 Study

Download Full-text

A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2015.07.2260 ◽

2015 ◽

Vol 93 (4) ◽

pp. 757-764 ◽

Cited By ~ 155

Author(s):

Gregory M.M. Videtic ◽

Chen Hu ◽

Anurag K. Singh ◽

Joe Y. Chang ◽

William Parker ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Stereotactic Body Radiation Therapy ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

Phase 2 Study ◽

Randomized Phase 2

Download Full-text

Final Results of a Randomized Phase 2 Study Comparing Carboplatin Plus Irinotecan (Ci) Versus Carboplatin Plus Amrubicin (Ca) for Extensive Disease Small-Cell Lung Cancer: Njlcg0901

Annals of Oncology ◽

10.1093/annonc/mdu355.14 ◽

2014 ◽

Vol 25 ◽

pp. iv515

Author(s):

Y. Tsukita ◽

N. Morikawa ◽

S. Sugawara ◽

M. Maemondo ◽

T. Harada ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase 2 ◽

Small Cell Lung ◽

Extensive Disease ◽

Phase 2 Study ◽

Randomized Phase 2

Download Full-text

Phase 2 Study of Afatinib Alone or Combined With Bevacizumab in Chemonaive Patients With Advanced Non–Small-Cell Lung Cancer Harboring EGFR Mutations: AfaBev-CS Study Protocol

Clinical Lung Cancer ◽

10.1016/j.cllc.2018.10.008 ◽

2019 ◽

Vol 20 (2) ◽

pp. 134-138 ◽

Cited By ~ 8

Author(s):

Takashi Ninomiya ◽

Nobuhisa Ishikawa ◽

Koji Inoue ◽

Toshio Kubo ◽

Masayuki Yasugi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Study Protocol ◽

Cell Lung Cancer ◽

Small Cell ◽

Egfr Mutations ◽

Phase 2 ◽

Small Cell Lung ◽

Phase 2 Study

Download Full-text

OA02.03 Clinical Activity of Lorlatinib in Patients with ROS1+ Advanced Non-Small Cell Lung Cancer: Phase 2 Study Cohort EXP-6

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2018.08.241 ◽

2018 ◽

Vol 13 (10) ◽

pp. S322-S323 ◽

Cited By ~ 11

Author(s):

S. Ou ◽

A. Shaw ◽

G. Riely ◽

R. Chiari ◽

J. Bauman ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Clinical Activity ◽

Study Cohort ◽

Phase 2 ◽

Small Cell Lung ◽

Phase 2 Study

Download Full-text

AOSOP15 PHASE 2 STUDY COMPARING CISPLATIN/ETOPOSIDE AND WEEKLY PACLITAXEL/CARBOPLATIN REGIMENS WITH CONCURRENT THORACIC RADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED NON-SMALL-CELL LUNG CANCER

European Journal of Cancer ◽

10.1016/s0959-8049(13)70014-5 ◽

2013 ◽

Vol 49 ◽

pp. S6

Author(s):

J. Liang ◽

W. Wang ◽

G. Ou ◽

Z. Hui ◽

J. Lv ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Locally Advanced ◽

Small Cell ◽

Weekly Paclitaxel ◽

Phase 2 ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Phase 2 Study

Download Full-text